A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Clinical trial NCT04763408 · COMPLETED
Trial details
- NCT number
- NCT04763408
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-09
- Primary completion
- 2023-12-13
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.